CGP-44826

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCGP-44826
Drug Alias NameCGP-44826
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene E4 receptor antagonistsLeukotriene D4 antagonists
TargetsLeukotriene E4 receptorLeukotriene D4
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCiba Geigy Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A